Ligand validation:2E75

OPC: (7R,17E)-4-HYDROXY-N,N,N,7-TETRAMETHYL-7-[(8E)-OCTADEC-8-ENOYLOXY]-10-OXO-3,5,9-TRIOXA-4-PHOSPHAHEPTACOS-17-EN-1-AMINIUM 4-OXIDE

OPC is a Ligand Of Interest in 2E75 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
2E75_OPC_B_1001	14%	7%	0.378	0.936	2.2	2.53	19	26	9	0	98%	0.9818
2E75_OPC_A_1002	9%	6%	0.398	0.895	2.16	2.84	14	27	21	0	98%	0.9818
2D2C_OPC_B_305	99%	38%	0.047	0.986	1.36	1.09	8	3	12	0	98%	0.9818
2E76_OPC_B_1001	65%	6%	0.142	0.947	2.28	2.71	23	25	2	0	98%	0.9818
1VF5_OPC_Q_1307	39%	35%	0.195	0.907	1.37	1.18	9	3	9	0	98%	0.9818
4PV1_OPC_B_205	39%	47%	0.202	0.912	1.06	1	2	2	4	0	98%	0.9818
2E74_OPC_B_202	26%	9%	0.274	0.922	2.07	2.43	14	13	2	0	98%	0.9818
4OGQ_OPC_B_205	43%	47%	0.225	0.953	1.05	1.01	3	2	3	0	98%	0.9818

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.